How can we achieve global equity in provision of renal replacement therapy?

PubWeight™: 3.00‹?› | Rank: Top 1%

🔗 View Article (PMC 2647401)

Published in Bull World Health Organ on March 01, 2008

Authors

Sarah L White1, Steven J Chadban, Stephen Jan, Jeremy R Chapman, Alan Cass

Author Affiliations

1: The George Institute for International Health, Royal Prince Alfred Hospital, Missenden Road, Sydney, NSW, Australia. sarahw@george.org.au

Articles citing this

Taming the chronic kidney disease epidemic: a global view of surveillance efforts. Kidney Int (2014) 2.33

Global trends in rates of peritoneal dialysis. J Am Soc Nephrol (2012) 2.29

Assessment of Global Kidney Health Care Status. JAMA (2017) 2.04

International survey of nephrologists' perceptions and attitudes about rewards and compensations for kidney donation. Nephrol Dial Transplant (2013) 1.45

Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country. PLoS One (2016) 1.39

Nephrology in china. Nat Rev Nephrol (2013) 1.38

The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One (2013) 1.16

Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry. Perit Dial Int (2012) 1.10

Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens (2014) 1.04

The global diffusion of organ transplantation: trends, drivers and policy implications. Bull World Health Organ (2014) 0.93

Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition. Int Health (2015) 0.90

Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions. NDT Plus (2009) 0.88

Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model. Exp Diabetes Res (2012) 0.88

Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies. BMC Cancer (2016) 0.86

Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon. BMC Nephrol (2015) 0.85

How to meet the demand for good quality renal dialysis as part of universal health coverage in resource-limited settings? Health Res Policy Syst (2016) 0.85

Incidence of end-stage renal disease in the Turkish-Cypriot population of Northern Cyprus: a population based study. PLoS One (2013) 0.84

Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety. BMC Med (2014) 0.84

Family income is associated with quality of life in patients with chronic kidney disease in the pre-dialysis phase: a cross sectional study. Health Qual Life Outcomes (2015) 0.82

Is the kidney disease quality of life-36 (KDQOL-36) a valid instrument for Chinese dialysis patients? BMC Nephrol (2014) 0.82

A global overview of renal registries: a systematic review. BMC Nephrol (2015) 0.82

Epidemiology of chronic kidney disease in northern region of Senegal: a community-based study in 2012. Pan Afr Med J (2014) 0.81

Why is organ transplantation clinically important? Cold Spring Harb Perspect Med (2013) 0.80

Patterns of health-related quality of life and associated factors in Chinese patients undergoing haemodialysis. Health Qual Life Outcomes (2015) 0.80

A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil. Perit Dial Int (2012) 0.79

International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data. Int J Nephrol (2015) 0.79

Chapter 4: Blood pressure management in CKD ND patients with diabetes mellitus. Kidney Int Suppl (2011) (2012) 0.79

Costs of Treatment after Renal Transplantation: Is it Worth to Pay More? Iran J Pharm Res (2014) 0.79

Prevalence of chronic kidney disease and associated factors in senegalese populations: a community-based study in saint-louis. Nephrourol Mon (2014) 0.78

Diffuse glomerular nodular lesions in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha, an inheritant diabetic gene in humans. PLoS One (2014) 0.78

The World Health Organization's Evidenced-Based Approach to Chronic Diseases: Primary Prevention or Caring for End-Stage Disease? Perm J (2009) 0.78

When health systems are barriers to health care: challenges faced by uninsured Mexican kidney patients. PLoS One (2013) 0.78

Comparison of plasma oxidative biomarkers and conformational modifications of hemoglobin in patients with diabetes on hemodialysis. Iran Red Crescent Med J (2014) 0.77

A renal registry for Africa: first steps. Clin Kidney J (2015) 0.77

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment. Diabetes Metab Syndr Obes (2013) 0.77

Disparities in dialysis allocation: An audit from the new South Africa. PLoS One (2017) 0.75

Early diagnosis saves lives: focus on patients with chronic kidney disease. Kidney Int Suppl (2011) (2013) 0.75

The Oxidative and Inflammatory State in Patients with Acute Renal Graft Dysfunction Treated with Tacrolimus. Oxid Med Cell Longev (2016) 0.75

Socioeconomic rehabilitation of successful renal transplant patients and impact of funding source: Indian scenario. Indian J Urol (2015) 0.75

Effect of angiotensin converting enzyme inhibitor on glomerular hyperfiltration in patients with type 1 diabetes. Pak J Med Sci (2016) 0.75

Process and barriers to organ donation and causes of brain death in northeast of Iran. Electron Physician (2017) 0.75

Types of vicarious learning experienced by pre-dialysis patients. SAGE Open Med (2015) 0.75

Living with moderate to severe renal failure from the perspective of patients. BMC Nephrol (2016) 0.75

SERVE Ethiopia. Perm J (2009) 0.75

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests. Iran J Public Health (2016) 0.75

West Meets East. Kidney Dis (Basel) (2015) 0.75

Chronic kidney disease: identification and management in primary care. Pragmat Obs Res (2016) 0.75

Comparison of Clinical Trajectories before Initiation of Renal Replacement Therapy between Diabetic Nephropathy and Nephrosclerosis on the KDIGO Guidelines Heat Map. J Diabetes Res (2015) 0.75

Current trends in European renal epidemiology. Clin Kidney J (2017) 0.75

Articles cited by this

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69

Economic and health consequences of selling a kidney in India. JAMA (2002) 6.58

The quality of life of patients with end-stage renal disease. N Engl J Med (1985) 5.10

A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation (2005) 3.94

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet (2006) 3.60

The incidence of end-stage renal disease in India: a population-based study. Kidney Int (2006) 2.85

The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int (2006) 1.99

End-stage renal disease in developing countries. Kidney Int (2002) 1.98

Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl (2005) 1.96

End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int Suppl (2003) 1.91

Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75

Polypill holds promise for people with chronic disease. Bull World Health Organ (2006) 1.48

ESRD patients in 2001: global overview of patients, treatment modalities and development trends. Nephrol Dial Transplant (2002) 1.38

Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16

Nephrology in China: a great mission and momentous challenge. Kidney Int Suppl (2003) 1.14

Payment for living organ donation should be legalised. BMJ (2006) 1.12

Preventive strategies of renal failure in the Arab world. Kidney Int Suppl (2005) 1.08

End-stage renal disease in North Africa. Kidney Int Suppl (2003) 1.06

Is renal replacement therapy for all possible in developing countries? Ethn Dis (2006) 1.01

Chronic kidney disease in Costa Rica. Kidney Int Suppl (2005) 0.98

A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97

The Latin American Dialysis and Transplantation Registry (RLDT) annual report 2004. Ethn Dis (2006) 0.97

The trade in human organs in Tamil Nadu: the anatomy of regulatory failure. Health Econ Policy Law (2006) 0.96

Nephrology in South East Asia: fact and concept. Kidney Int Suppl (2003) 0.93

Nephrology in Latin America, with special emphasis on Brazil. Kidney Int Suppl (2003) 0.92

Health care financing and delivery in developing countries. Health Aff (Millwood) (1999) 0.89

Nephrologists sans frontières: preventing chronic kidney disease on a shoestring. Kidney Int (2006) 0.88

Need for increasing transplant activity: a sustainable model for developing countries. Transplant Proc (1997) 0.85

End-stage renal disease prevention strategies in Latin America. Kidney Int Suppl (2005) 0.84

Early detection and prevention of diabetic nephropathy: a challenge calling for mandatory action for Mexico and the developing world. Kidney Int Suppl (2005) 0.84

Gender disparity in a live donor renal transplantation program: assessing from cultural perspectives. Transplant Proc (2003) 0.84

The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis (2004) 0.84

Organ transplantation in developing countries. World Health Forum (1998) 0.81

Transplantation in developing countries: economics, reality, and solutions. Transplant Proc (2000) 0.81

Opportunities for a chronic disease outreach program in China. Kidney Int Suppl (2005) 0.81

Culture and psychology in organ transplantation. World Health Forum (1998) 0.80

The global perspective of the International Society of Nephrology: a decade of experience with COMGAN. Kidney Int (2005) 0.80

Articles by these authors

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med (2012) 11.83

Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med (2009) 9.77

The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet (2010) 6.23

TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest (2007) 4.77

Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet (2009) 4.73

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42

Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40

Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29

Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis (2010) 3.28

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72

Feasibility, acceptability and cost of home-based HIV testing in rural Kenya. Trop Med Int Health (2009) 2.63

Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study). Med J Aust (2010) 2.62

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55

Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54

Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34

An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med (2012) 2.27

Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke (2009) 2.13

Economic assessment of a women's group intervention to improve birth outcomes in rural Nepal. Lancet (2005) 2.12

Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol (2008) 2.06

Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med (2014) 2.02

Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation. Kidney Int (2009) 1.96

Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis (2004) 1.94

Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94

A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl (2003) 1.90

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ (2005) 1.90

Reduction in cardiovascular death after kidney transplantation. Transplantation (2010) 1.89

HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol (2010) 1.89

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care (2009) 1.89

Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med (2009) 1.86

Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2012) 1.84

The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med (2008) 1.83

Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation (2004) 1.82

How do we determine whether community health workers are cost-effective? Some core methodological issues. J Community Health (2005) 1.81

Chronic allograft nephropathy: current concepts and future directions. Transplantation (2006) 1.79

The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis (2012) 1.78

Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis (2002) 1.78

The effect of fiscal policy on diet, obesity and chronic disease: a systematic review. Bull World Health Organ (2010) 1.77

Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial. J Am Coll Cardiol (2010) 1.74

Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. Am J Kidney Dis (2010) 1.74

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J (2013) 1.74

Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol (2009) 1.68

A systematic review of the costs and benefits of helicopter emergency medical services. Injury (2010) 1.67

The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int (2009) 1.66

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ (2012) 1.63

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation (2006) 1.63

Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62

Cause of death in patients with end-stage renal disease: assessing concordance of death certificates with registry reports. Aust N Z J Public Health (2003) 1.61

Timing of renal replacement therapy and patient outcomes in the randomized evaluation of normal versus augmented level of replacement therapy study. Crit Care Med (2014) 1.60

Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation (2004) 1.58

Association of CKD and cancer risk in older people. J Am Soc Nephrol (2009) 1.57

Access to renal transplantation among American Indians and Hispanics. Am J Kidney Dis (2004) 1.56

Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int (2012) 1.53

Time on dialysis and cancer risk after kidney transplantation. Transplantation (2013) 1.53

Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: a systematic review and meta-analysis. Anesthesiology (2013) 1.51

Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) (2006) 1.51

Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). Nephrol Dial Transplant (2011) 1.50

Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable? Transplantation (2012) 1.50

Achieving a balanced life in the face of chronic illness. Aust J Prim Health (2010) 1.49

Health professionals, patients and chronic illness policy: a qualitative study. Health Expect (2011) 1.49

The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) (2009) 1.48

The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant (2009) 1.48

Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Nephrol Dial Transplant (2012) 1.48

Socioeconomic disparities in stroke rates and outcome: pooled analysis of stroke incidence studies in Australia and New Zealand. Med J Aust (2011) 1.48

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant (2013) 1.47

Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis. Intensive Care Med (2013) 1.46

Childhood obesity, values and the market. Int J Pediatr Obes (2006) 1.46

Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45

Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust (2003) 1.44

The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: a registry analysis. Transplantation (2014) 1.44

Prospective psychosocial monitoring of living kidney donors using the SF-36 health survey. Transplantation (2003) 1.44

Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med (2013) 1.44

Gaps in cardiovascular disease risk management in Australian general practice. Med J Aust (2009) 1.42

Epidemiology of RBC Transfusions in Patients With Severe Acute Kidney Injury: Analysis From the Randomized Evaluation of Normal Versus Augmented Level Study. Crit Care Med (2016) 1.42

Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities. PLoS One (2012) 1.42

The relative benefits and costs of solid phase bead technology to detect preformed donor specific antihuman leukocyte antigen antibodies in determining suitability for kidney transplantation. Transplantation (2015) 1.40

Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis (2008) 1.39

Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients. Transplantation (2014) 1.39

How fair is Medicare? The income-related distribution of Medicare benefits with special focus on chronic care items. Med J Aust (2012) 1.39

Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression. Transpl Int (2008) 1.37

Trade and the nutrition transition: strengthening policy for health in the Pacific. Ecol Food Nutr (2011) 1.35

Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. Eur Heart J (2010) 1.34

The role of macrophages in allograft rejection. Transplantation (2005) 1.32

Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation (2003) 1.32

Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. J Am Soc Nephrol (2007) 1.31

Socio-economic distribution of cardiovascular risk factors and knowledge in rural India. Int J Epidemiol (2012) 1.30

The role of regulation in influencing income-generating activities among public sector doctors in Peru. Hum Resour Health (2007) 1.30

Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit. Med J Aust (2009) 1.28

Ten principles relevant to health research among Indigenous Australian populations. Med J Aust (2012) 1.28

Community preferences for the allocation of solid organs for transplantation: a systematic review. Transplantation (2010) 1.26

Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int Suppl (2004) 1.26

Economic hardship associated with managing chronic illness: a qualitative inquiry. BMC Health Serv Res (2009) 1.25

The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev (2012) 1.25

Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24

Cancer after renal transplantation: the next challenge. Am J Transplant (2004) 1.23